Our results clearly demonstrate that in preclinical models, regulation of T cell function in tumours by PD-L1/PD-1 involves more than just a simple adaptive response by the tumour cells themselves, but rather involves an intimate and complex interchange between the tumour and its immune microenvironment. The gene discussed is CD274; the disease is neoplasm.